Working… Menu
Help guide our efforts to modernize
Send us your comments by March 14, 2020.

A Study of a Personalized Cancer Vaccine Targeting Shared Neoantigens

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03953235
Recruitment Status : Recruiting
First Posted : May 16, 2019
Last Update Posted : December 26, 2019
Bristol-Myers Squibb
Information provided by (Responsible Party):
Gritstone Oncology, Inc.

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 2022
Estimated Study Completion Date : December 2023